tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
KYMR is currently covered by 22 analysts with an average price target of $123.14. This is a potential upside of $18.36 (17.52%) from yesterday's end of day stock price of $104.78.
Kymera Therapeutics's activity chart (see below) currently has 207 price targets and 202 ratings on display. The stock rating distribution of KYMR is 98.15% BUY and 1.85% HOLD.
Analysts average stock forecasts to be materialized ratio is 89.49% with an average time for these price targets to be met of 293.23 days.
Highest price target for KYMR is $170, Lowest price target is $67, average price target is $123.14.
Most recent stock forecast was given by GEOFF MEACHAM from CITI on 05-Oct-2026. First documented stock forecast 15-Sep-2020.
Currently out of the existing stock ratings of KYMR, 53 are a BUY (98.15%), 1 are a HOLD (1.85%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-Jun-2025
$150
$45.22 (43.16%)
$120
13 days ago
(05-Oct-2026)
8/9 (88.89%)
$40.15 (36.55%)
116
Buy Since 20-May-2025
$152
$47.22 (45.07%)
$114
26 days ago
(22-Sep-2026)
4/5 (80%)
$29.94 (24.53%)
145
Buy Since 30-Jun-2026
$144
$39.22 (37.43%)
$125
1 months 4 days ago
(14-Sep-2026)
3/4 (75%)
$29.37 (25.62%)
67
Hold Since 10-Sep-2026
$92
1 months 8 days ago
(10-Sep-2026)
3/3 (100%)
$18.91 (25.87%)
195
Buy Since 29-Sep-2021
$170
$65.22 (62.24%)
$135
1 months 17 days ago
(31-Aug-2026)
9/11 (81.82%)
$51.19 (43.09%)
554
What is KYMR (Kymera Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on KYMR (Kymera Therapeutics)?
Which analyst has the most public recommendations on KYMR (Kymera Therapeutics)?
Which analyst is the currently most bullish on KYMR (Kymera Therapeutics)?
Which analyst is the currently most reserved on KYMR (Kymera Therapeutics)?
